Alison Siedor

Alison Siedor

Goodwin

Contact
View Bio
RSS

Latest Posts › Labeling

Share:

FDA Releases Draft Labeling Guidance for Biosimilar Products

Last week, FDA released a draft guidance, “Labeling for Biosimilar and Interchangeable Biosimilar Products” (“2023 Draft Guidance”) that—when finalized—will revise and replace its July 2018 final guidance, “Labeling for...more

9/26/2023  /  Biosimilars , Comment Period , Draft Guidance , Food and Drug Administration (FDA) , Interchangeability , Labeling , Pharmaceutical Industry , Prescription Drugs , Product Labels , Warning Labels

Is it Biosimilar or Interchangeable? It Won’t Be Easy to Tell Under FDA’s Latest Draft Labeling Guidance

Last week, FDA released a draft guidance, “Labeling for Biosimilar and Interchangeable Biosimilar Products” that—when finalized—will revise and replace its July 2018 final guidance, “Labeling for Biosimilar Products.” FDA...more

9/25/2023  /  Biosimilars , Comment Period , Draft Guidance , Food and Drug Administration (FDA) , Interchangeability , Labeling , Pharmaceutical Industry , Prescription Drugs
2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide